In less than a year, millions of Americans may face losing their Medicaid coverage due to new eligibility restrictions, potentially leading to missed cancer screenings that could be life-saving. A recent analysis published in JAMA Oncology estimates that over a million cancer screenings for colorectal, breast, or lung cancer may be missed in the two years following the implementation of these new policies.
The One Big Beautiful Bill, signed into law by President Trump on July 4th last year, includes significant cuts to Medicaid totaling around $1 trillion. These cuts were intended to help offset the cost of large tax cuts and address rising Medicaid expenses. However, health experts, advocates, and lawmakers raised concerns that these cuts would result in millions of individuals losing insurance coverage, potentially leading to preventable deaths. The new Medicaid eligibility requirements, including work requirements and more frequent eligibility verification, are set to take effect on January 1, 2027.
To assess the potential impact of these changes, researchers developed a model based on real-world data from Arkansas’s implementation of a work requirement in 2018 and the easing of re-verification requirements during the Covid-19 pandemic. The model predicted that the loss of Medicaid coverage could result in nearly 1.2 million missed cancer screenings and 155 preventable deaths within two years.
Dr. Adrian Diaz, a surgical oncologist at the University of Chicago and one of the study’s authors, emphasized the importance of early cancer detection through screenings. He expressed concern that the new Medicaid restrictions could significantly impact access to screenings for vulnerable populations, potentially leading to delayed diagnoses and poorer outcomes for patients.
The study highlighted the challenges individuals may face in maintaining Medicaid coverage, such as administrative burdens and errors that can result in coverage lapses. These lapses could have serious consequences for patients already undergoing cancer treatment, potentially disrupting their care and leading to additional stress and complications.
In addition to the missed screenings, the study also projected an increase in advanced-stage cancer diagnoses and avoidable deaths as a result of delayed or foregone screenings. Dr. Diaz emphasized the significance of these findings, noting that each avoidable death represents a tragic loss for families and communities.
As policymakers consider the implications of these Medicaid eligibility changes, it is crucial to prioritize access to essential healthcare services, including cancer screenings, for all individuals. Addressing barriers to coverage and ensuring timely access to screenings are essential steps in reducing disparities in cancer care and improving outcomes for patients nationwide.
